Home » Valeant Pharmaceuticals Acquires Visudyne From QLT
Valeant Pharmaceuticals Acquires Visudyne From QLT
Valeant Pharmaceuticals announced it has acquired Visudyne, used to treat abnormal growth of leaky blood vessels in the eye caused by wet age-related macular degeneration, from QLT.
The Sacramento Bee
The Sacramento Bee
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May